| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 09/19/2000 | US6121004 Autoantibodies and their targets in the diagnosis of peripheral neuropathies |
| 09/19/2000 | US6120774 Heterophil-adapted poultry vaccine |
| 09/14/2000 | WO2000053776A2 Human kallikrein-like genes |
| 09/14/2000 | WO2000053775A2 Prevention and treatment of viral infections |
| 09/14/2000 | WO2000053747A1 Sialic acid-binding ig-like lectin (siglec) gene; ob-binding protein like (ob-bpl) |
| 09/14/2000 | WO2000053738A2 Methods and compositions for regulating memory consolidation |
| 09/14/2000 | WO2000053005A1 HETEROGENOUS AND HOMOGENEOUS MOUSE VARIANTS LACKING sno GENE |
| 09/14/2000 | WO2000053004A1 Non-human model for human endometriosis |
| 09/14/2000 | WO2000037504A3 Human monoclonal antibodies to ctla-4 |
| 09/14/2000 | WO2000036909A3 In vivo odontogenic model using rodent's mandibular incisor |
| 09/14/2000 | WO2000023588B1 G-protein coupled receptors |
| 09/14/2000 | CA2367067A1 Heterogenous and homogeneous mouse variants lacking sno gene |
| 09/14/2000 | CA2366429A1 Methods and compositions for regulating memory consolidation |
| 09/14/2000 | CA2366087A1 Sialic acid-binding ig-like lectin (siglec) gene; ob-binding protein like (ob-bpl) |
| 09/14/2000 | CA2362885A1 Human kallikrein-like genes |
| 09/14/2000 | CA2361370A1 Prevention and treatment of viral infections |
| 09/13/2000 | WO2001019181A1 Cloning pigs using donor cells or nuclei from differentiated cells and production of pluripotent porcine. |
| 09/13/2000 | EP1035208A1 VARIANT loxP SEQUENCES AND APPLICATION OF THE SAME |
| 09/13/2000 | EP1034786A1 Method for delivering direct feed microorganisms to poultry in ovo |
| 09/13/2000 | EP1034308A1 Method of generating conditionally expressed mutant cells using expressible antisense sequences |
| 09/13/2000 | EP1034281A1 MAMMARY GLAND TISSUE-SPECIFIC EXPRESSION SYSTEM USING $G(b)-CASEIN PROMOTER SITE OF KOREAN NATIVE GOAT |
| 09/13/2000 | EP1034273A1 Histamine and serotonin binding molecules |
| 09/13/2000 | EP1034271A2 Transgenic non-human mammals with an oncogenic mutant of raf gene 1 |
| 09/13/2000 | EP1034258A2 Nucleic acid transfer vector for the introduction of nucleic acid into the dna of a cell |
| 09/13/2000 | EP1034257A2 Yac vectors |
| 09/13/2000 | EP0733059B1 Compounds and methods for site-directed mutations in eukaryotic cells |
| 09/13/2000 | CN1265828A Toxin extraction method from living body of poisonous spider |
| 09/13/2000 | CA2381124A1 Cloning pigs using donor cells or nuclei from differentiated cells and production of pluripotent porcine |
| 09/12/2000 | US6118045 Mammal having transgene with promoter and enhancer from same mammary gland specific gene, signal sequence for mammary secretory cells, and recombinant dna coding for acid alpha glucosidase; processed/secreted enzyme for pompe's disease |
| 09/12/2000 | US6118044 Transgenic animal allergy models and methods for their use |
| 09/12/2000 | US6117978 Protein having at least 63% identity to human protein having defined amino acid sequence; for diagnosis and therapy of alzheimer's disease; drug screening |
| 09/08/2000 | WO2000052462A1 Heart abnormalities in vascular endothelial growth factor b (vegf-b) deficient animals and methods relating to these heart abnormalities |
| 09/08/2000 | WO2000052206A1 Detection and quantification of micro-organisms using amplification and restriction enzyme analysis |
| 09/08/2000 | WO2000052149A1 Introducing a biological material into a patient |
| 09/08/2000 | WO2000051647A2 Animal model of allergies |
| 09/08/2000 | WO2000051424A2 Genetic modification of somatic cells and uses thereof |
| 09/08/2000 | WO2000013702A3 Use of an angiogenic factor for the treatment of microvascular angiopathies |
| 09/08/2000 | WO2000012720A3 Elongase genes and uses thereof |
| 09/08/2000 | WO2000012702A3 Human genes differentially expressed in colorectal cancer |
| 09/08/2000 | WO2000000604A9 Methods and compositions for modulating spermatogenesis |
| 09/08/2000 | CA2367587A1 Detection and quantification of micro-organisms using amplification and restriction enzyme analysis |
| 09/08/2000 | CA2364463A1 Introducing a biological material into a patient |
| 09/08/2000 | CA2363488A1 Heart abnormalities in vascular endothelial growth factor b (vegf-b) deficient animals and methods relating to these heart abnormalities |
| 09/06/2000 | EP1032674A2 $i(CHLAMYDIA PNEUMONIAE) GENOMIC SEQUENCE AND POLYPEPTIDES, FRAGMENTS THEREOF AND USES THEREOF, IN PARTICULAR FOR THE DIAGNOSIS, PREVENTION AND TREATMENT OF INFECTION |
| 09/06/2000 | EP1032671A1 Mammalian cytokine-like polypeptide-10 |
| 09/06/2000 | EP1032595A2 Nucleic acids involved in the responder phenotype and applications thereof |
| 09/06/2000 | EP1032423A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof |
| 09/06/2000 | CN2394443Y Katydia cage capable of heating and lighting |
| 09/06/2000 | CN1265600A Cloning pigs using donor nuclei from differentiated cells |
| 09/06/2000 | CN1265599A Cloning using donor nuclei from non-serum starved, differentiated cells |
| 09/05/2000 | US6114599 Producing glucose regulated insulin producing cells whose proliferation is regulated by tetracycline; introducing into cells a tetracycline fusion protein gene, an insulin promoter and a gene encoding an sv40 antigen and tetracycline promoter |
| 09/05/2000 | US6114598 Generation of xenogeneic antibodies |
| 09/05/2000 | US6114168 Active retinoic acid-free culture medium for chicken embryonic stem cells |
| 08/31/2000 | WO2000050892A1 An in vivo and in vitro model for cutaneous photoaging and oxidative damage |
| 08/31/2000 | WO2000050608A1 Novel polypeptide |
| 08/31/2000 | WO2000050566A2 Genes encoding insect odorant receptors and uses thereof |
| 08/31/2000 | WO2000050565A2 Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene |
| 08/31/2000 | WO2000050562A2 Dna encoding snorf25 receptor |
| 08/31/2000 | WO2000049897A1 Artificial diets for arthropods |
| 08/31/2000 | WO2000049876A1 System and method for evaluating agents which prevent oxidative damage |
| 08/31/2000 | WO2000049862A1 Transgenic mollusc and method for constructing the same |
| 08/31/2000 | WO2000049861A1 Vertically and continuously breeding worms |
| 08/31/2000 | WO2000028040A3 Cloning of rhadinovirus genome and methods for its use |
| 08/31/2000 | CA2365019A1 Novel polypeptide |
| 08/31/2000 | CA2364966A1 Genes encoding insect odorant receptors and uses thereof |
| 08/31/2000 | CA2362906A1 Dna encoding snorf25 receptor |
| 08/31/2000 | CA2362904A1 System and method for evaluating agents which prevent oxidative damage |
| 08/31/2000 | CA2362585A1 An in vivo and in vitro model for cutaneous photoaging and oxidative damage |
| 08/31/2000 | CA2361396A1 Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene |
| 08/30/2000 | EP1031287A1 Drinking water additive for birds and method of administering the same |
| 08/30/2000 | EP1030929A1 Transfection and transfer of male germ cells for generation of transgenic species |
| 08/30/2000 | EP1030926A2 Transgenic models of inflammatory disease |
| 08/30/2000 | EP1030919A2 Cdk2 protein and cdk2 protein complexes |
| 08/30/2000 | EP1030916A2 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis |
| 08/30/2000 | CN2393336Y Blood supplier for bloodsuckers |
| 08/30/2000 | CN1265148A Anticoagulant fusion protein anchored to cell membrane |
| 08/29/2000 | US6111166 Transgenic mice expressing human Fcα and β receptors |
| 08/29/2000 | US6111165 Production of human recombinant collagen in the milk of transgenic animals |
| 08/29/2000 | US6110700 Nucleic acids that code a modulator of kinase activity; for the diagnosis tumorous condition; for development of models for the evaluation cancer in organ and tissues |
| 08/29/2000 | US6110666 Detection of regulatory sequences; transforming a cell with a genetically engineered expression vector, monitor preferential gene expression in cell |
| 08/29/2000 | US6110480 Method for preparing an environmentally compatable porous material comprising beneficial nematodes and the biotic preparations produced therefrom |
| 08/24/2000 | WO2000049153A1 Fucosyl transferase gene |
| 08/24/2000 | WO2000049150A1 Chimeric gene constructs for generation of fluorescent transgenic ornamental fish |
| 08/24/2000 | WO2000049147A1 Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy |
| 08/24/2000 | WO2000049132A2 Uses of transgenic animals containing a type x collagen mutant |
| 08/24/2000 | WO2000031126A3 Suppression of xenotransplant rejection |
| 08/24/2000 | WO2000023100A9 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 08/24/2000 | WO2000018917A9 α-SYNUCLEIN SUPER-MUTANTS ACCELERATE α-SYNUCLEIN AGGREGATION |
| 08/24/2000 | WO2000015772A9 Recombinant protein production in urine |
| 08/24/2000 | CA2362970A1 Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy |
| 08/23/2000 | EP1029918A1 Killer t cell receptor recognizing human immunodeficiency virus |
| 08/23/2000 | EP1029051A1 Genes with restricted expression in mesencephalic dopaminergic neurons |
| 08/23/2000 | EP1029039A1 Non-transgenic animal model of alzheimer's disease |
| 08/23/2000 | EP1029038A1 Mammals lacking expression of osteoprotegerin |
| 08/23/2000 | EP1029037A1 Transgenic animals bearing stress sensitive regulatory sequences |
| 08/23/2000 | EP1028754A1 Prevention of immunoreactivity by depleting or inhibiting antigen presenting cells |
| 08/23/2000 | EP0866799A4 Apolipoprotein e2 and treatment of alzheimer's disease |
| 08/23/2000 | CN1264429A Metastasis models using green fluorescent protein (GFP) as marker |
| 08/23/2000 | CN1263704A Method for breeding tetraploid fish |
| 08/23/2000 | CN1263703A Method for breeding triploid crucian carp (common carp) and apparatus thereof |